Skip to main content
Caplight Logo









Pharosyn

Pharosyn

Private
LondonHealthcare & Life Scienceshttps://www.pharosyn.ai/

Last Round

Seed

Sep 2, 2026

Total Funding Raised

$3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pharosyn is an AI-powered competitive intelligence company that provides a platform for pharmaceutical and biopharma teams to monitor clinical, regulatory, and commercial data for strategic decision-making.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence, Biotechnology, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

competitive intelligencebiopharma intelligencepharma analyticsAI copilotstrategic intelligenceclinical data monitoringregulatory monitoringpharma SaaSmarket research automationportfolio strategybusiness intelligenceworkflow automationexpert networkvibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharosyn Comparables

Compare Pharosyn with similar companies based on industry and business-model similarity.

Pharosyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Norstella
72%
Atacana Group
71%
Clarivate Plc
70%

Pharosyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 2, 2026

Key People

Founding team and executive leadership

Stephen Cowley

Co-Founder and CEO

Founding Team

Pharosyn Investors

Notable investors and investment history

Pharosyn investors
InvestorRounds
Transpose PlatformPre Seed, Seed
Entrepreneurs FirstPre Seed, Seed
MoonfirePre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2026

    $3M round led by Moonfire.

Recent news

Latest coverage and updates

  • receives_financingSep 3, 2026

    Pharosyn received financing of $3M in Seed on Sep 2nd '26.

Pharosyn Filings

Explore SEC and related filing metadata, where available.

Pharosyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pharosyn's valuation, stock price, and market status.

Is Pharosyn a public or private company?

Pharosyn is a private company.

What is the current stock price of Pharosyn?

Pharosyn is a private company with no public stock price. Caplight tracks Pharosyn's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Pharosyn worth (valuation)?

Valuation information for Pharosyn is not publicly available.

Can I buy Pharosyn stock?

Pharosyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pharosyn's last funding round?

Pharosyn's most recent funding round was Seed on September 2, 2026.

Who are the main investors in Pharosyn?

Key investors in Pharosyn include Moonfire.

Will Pharosyn IPO soon?

No public IPO plans have been announced for Pharosyn.

How can I track Pharosyn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharosyn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range4
Year Founded2025
Last FundingSep 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?